Marvel BiosciencesMBCOF +4.74%33 Days Payable is 1,863.61 as of Apr. 2026, which is 764% above its 10-year median of 215.79. GuruFocus rates MBCOF with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 708 Biotechnology companies, Marvel Biosciences ranks better than 89.41% on this metric.
The historical rank and industry rank for Marvel Biosciences's Days Payable or its related term are showing as below:
MBCOF'
s Days Payable Range Over the Past 10 Years
Min: 28.58 Med: 215.79 Max: 1544.6
Current: 1407.67
During the past 6 years, Marvel Biosciences's highest Days Payable was 1544.60. The lowest was 28.58. And the median was 215.79.
MBCOF's Days Payable is ranked better than 89.41% of 708
companies
in the Biotechnology industry
Industry Median: 113.56
vs MBCOF: 1407.67
Marvel Biosciences's Days Payable
increased
from Apr. 2025 (0.00) to Apr. 2026 (1,863.61).
It may suggest that Marvel Biosciencesdelayed paying its suppliers.
Marvel Biosciences Days Payable Related Terms
Marvel Biosciences Days Payable Historical Data
* Premium members only.
The historical data trend for Marvel Biosciences's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MBCOF vs VRTX, REGN, ALNY: Days Payable Comparison
For the Biotechnology subindustry, Marvel Biosciences's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Marvel Biosciences Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Marvel Biosciences's Days Payable distribution charts can be found below:
* The bar in red indicates where Marvel Biosciences's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Marvel Biosciences's Days Payable for the fiscal year that ended in Jul. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Marvel Biosciences (MBCOF) has a Days Payable of 1,863.61 as of Apr. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Marvel Biosciences and its competitors. This is 764% above median its historical median of 215.79. Over the past decade, Marvel Biosciences' Days Payable has ranged from 28.58 to 1,544.60. According to the industry distribution chart, Marvel Biosciences ranks #75 out of 708 companies in the Biotechnology industry, placing it in the top 10.6%.
Is Marvel Biosciences' Days Payable too high?
Marvel Biosciences' current Days Payable of 1,863.61 is 764% above median its 10-year median of 215.79. Over the past 10 years, this metric has ranged from a low of 28.58 to a high of 1,544.60. The Biotechnology industry median Days Payable is 113.56. Marvel Biosciences' value of 1,863.61 is 1541.1% above this industry median. Based on the distribution chart, Marvel Biosciences ranks #75 out of 708 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Marvel Biosciences has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Marvel Biosciences' Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Marvel Biosciences ranks #75 out of 708 companies for Days Payable. This places Marvel Biosciences in the top 11% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.56. Marvel Biosciences' value of 1,863.61 is 1541.1% above this benchmark. Historically, Marvel Biosciences' own Days Payable has ranged from 28.58 to 1,544.60 over the past decade. While the company's 10-year median is 215.79 vs. the industry median of 113.56, Marvel Biosciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.56, based on 708 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Marvel Biosciences's current Days Payable of 1,863.61 is 1541.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Marvel Biosciences and its competitors. For the Biotechnology industry, the median Days Payable is 113.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Marvel Biosciences's current Days Payable is 1,863.61, which is 764% above median its own 10-year median of 215.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Marvel Biosciences stock overvalued right now?
Marvel Biosciences (MBCOF) has a current Days Payable of 1,863.61. The current Days Payable is 1,863.61, which is 764% above median its 10-year median of 215.79 and 1541.1% above the Biotechnology industry median of 113.56. Marvel Biosciences' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Marvel Biosciences (MBCOF), the current Days Payable is 1,863.61 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Marvel Biosciences Corp is a biotechnology company incorporated in Canada. The Company is currently a pre-clinical stage pharmaceutical development company that utilizes a drug redevelopment approach to identify and evaluate potential therapeutic compounds. Its activities mainly involve scientific research and pre-clinical studies aimed at determining viable active compounds for further drug development.
33GF Score
Get the complete analysis for MBCOF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MBCOF has been successfully added to your 
